Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Oncology
Biotech
Senti slams brakes on CAR-NK program to eke out remaining cash
Senti, seeing the end of its cash runway hove into view, has dropped its liver cancer candidate and narrowed its focus onto two CAR-NK programs.
Nick Paul Taylor
Jan 27, 2023 9:40am
Celularity warns substantial slice of staff of possible layoffs
Jan 27, 2023 6:30am
Phase 2 attrition jumps amid scale-back in trial activity
Jan 18, 2023 6:42am
AbbVie pays Anima $42M to go after undruggable targets
Jan 10, 2023 9:15am
Belharra's wave catches Genentech in $130M launch
Jan 4, 2023 10:45am
Astellas posts 2nd phase 3 win in a month for oncology antibody
Dec 16, 2022 7:45am
More News
No surprises: FDA rejects Y-mAbs' rare pediatric cancer drug
Dec 2, 2022 5:43am
ImmunityBio, aiming to hire 300 in 30 months, lays off staff
Oct 10, 2022 8:52am
BMS, ConcertAI ally to promote oncology digital clinical trials
Oct 6, 2022 5:00am
Bayer parts with AI drug hunter Exscientia
Aug 18, 2022 10:00am
See more